US2023210804A1PendingUtilityA1

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

78
Assignee: FLAMEL IRELAND LTDPriority: Jul 22, 2016Filed: Mar 10, 2023Published: Jul 6, 2023
Est. expiryJul 22, 2036(~10 yrs left)· nominal 20-yr term from priority
Inventors:Jordan DubowHervé GuillardClaire MégretJean-François Dubuisson
A61K 9/5042A61K 9/5015A61K 9/14A61K 9/1676A61K 9/5084A61K 9/5026A61K 31/22A61K 31/19A61K 9/5078A61K 9/10
78
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method of treating cataplexy or excessive daytime sleepiness in a human subject with narcolepsy as disclosed herein.

Join the waitlist — get patent alerts

Track US2023210804A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.